Vascular Solutions Earnings: Here’s Why Investors are Excited Now
Vascular Solutions Inc. (NASDAQ:VASC) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 1.66%.
Vascular Solutions Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 13.33% to $0.17 in the quarter versus EPS of $0.15 in the year-earlier quarter.
Revenue: Rose 10.75% to $27.4 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Vascular Solutions Inc. reported adjusted EPS income of $0.17 per share. By that measure, the company missed the mean analyst estimate of $0.17. It beat the average revenue estimate of $27 million.
Quoting Management: “Vascular Solutions reported another very strong quarter, with continued double-digit sales growth to a new record quarterly level combined with ongoing improvement in our operating margin,” said Howard Root, Chief Executive Officer of Vascular Solutions. “We are especially pleased to achieve growth in all three of our product categories in light of the continuing challenges in the global healthcare environment. Our consistently strong financial performance reflects our demonstrated ability to develop and launch clinically-relevant new products on a continuing basis. With approximately ten new products scheduled for launch this year and 40 total new product ideas in our pipeline, we remain optimistic about our continued revenue and earnings growth for 2013 and beyond.”
Key Stats (on next page)…
Revenue increased 5.14% from $26.06 million in the previous quarter. EPS increased 6.25% from $0.16 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.17 and has not changed. For the current year, the average estimate has moved down from a profit of $0.68 to a profit of $0.67 over the last ninety days.